MedTrace Logo

Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma

NCT02798510 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2016-06-22

No results posted yet for this study

Summary

The present study is designed to determine whether adjuvant concurrent chemoradiotherapy improves overall survivals.

Conditions

  • Malignant Neoplasm Other Gallbladder/Extrahepatic Bile Duct

Interventions

RADIATION

Concurrent Chemoradiotherapy

DRUG

capecitabine

DRUG

gemcitabine

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • zhigang ren, MD · Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2019-04-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02798510 on ClinicalTrials.gov